Printer Friendly
The Free Library
14,679,458 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

HIV drug resistance.


A late breaking study presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy Antimicrobial Agents and Chemotherapy (print-ISSN 0066-4804, CODEN AMACCQ; canceled ISSN 0074-9923, canceled CODEN AACHAX) is an academic journal published by the American Society for Microbiology.  demonstrated that phenotypic HIV drug resistance testing HIV drug resistance testing Phenotype testing AIDS The testing of various agents–eg, reverse transcriptase inhibitors, for efficacy against a particular strain of HIV Types Genotypic tests1, phenotypic test. Cf Genotype testing.  is superior to treatment history in predicting sustained HIV suppression in antiretroviral therapy. Dr. Michael Saag of the University of Alabama The University of Alabama (also known as Alabama, UA or colloquially as 'Bama) is a public coeducational university located in Tuscaloosa, Alabama, USA. Founded in 1831, UA is the flagship campus of the University of Alabama System. , Birmingham described, the use of ViroLogic's phenotypic drug susceptibility assay, PhenoSense HIV, which directly measures the sensitivity or resistance of HIV. Two studies were published in JAMA JAMA
abbr.
Journal of the American Medical Association
 1999; 282:1135 and 1142.
COPYRIGHT 1999 Nelson Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Medical Laboratory Observer
Article Type:Brief Article
Date:Nov 1, 1999
Words:75
Previous Article:Alzheimer's disease.(Brief Article)
Next Article:Pathogens.(Brief Article)(Product Announcement)
Topics:



Related Articles
AZT-resistant HIV seen.
Blood, semen harbor distinct HIV mutations.(different patterns of drug resistance in blood and semen can be caused by genetic mutations)(Brief...
One more reason to worry.(antiviral drugs causing AIDS virus to mutate)(Brief Article)
Test identifies HIV patients hypersusceptible to NNRTI therapy.(non-nucleoside reverse transcriptase inhibitors)(Brief Article)
New HIV drugs in the pipeline: drug companies have dozens of new anti-HIV drugs under study, with many advantages--and a few drawbacks--compared with...
Major HIV treatment conference in Paris--finding reports online.(International AIDS Society Conference on HIV Pathogenesis and Treatment, July 13-16,...
Proof of concept studies/translational research; new hypotheses: (a personal take on Panel 2. Discussion leader: Kimberly Struble).(Essays)
Behind "AIDS breakthrough" headlines, December 2004: important research, not so new.(experimental antiretrovirals)
Tipranavir (Aptivus): approval cautiously recommended.
What's new in treatment news.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles